Fingerprint
Dive into the research topics of 'A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase 2 randomized trial of ELND005, scyllo-inositol, in mild to moderate Alzheimer disease
S. Salloway, R. Sperling, R. Keren, A. P. Porsteinsson, C. H. Van Dyck, P. N. Tariot, S. Gilman, D. Arnold, S. Abushakra, C. Hernandez, G. Crans, E. Liang, G. Quinn, M. Bairu, A. Pastrak, J. M. Cedarbaum
Research output: Contribution to journal › Article › peer-review
239
Scopus
citations